Bayer sets up innovation center in Shanghai

With an investment of approximately 20 million euros ($21.69 million), Bayer Consumer Health launched the China Center of Innovation and Partnership (CCIP) in Shanghai on Wednesday, aiming to integrate more deeply into the country's innovation ecosystem.

The CCIP is committed to building an integrated innovation partnership network that connects efforts from the industry, academia and research, with the aim of accelerating and transforming R&D innovation and scientific achievements in China, a market expected to continue rapid growth in the coming years for the consumer health business of Bayer.

China is one of the strongest growth engines for Bayer globally, and the second-largest market for consumer health, mainly including categories such as nutrition, digestive health and skincare.